2023
DOI: 10.3390/ijms241814402
|View full text |Cite
|
Sign up to set email alerts
|

Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer

Jingjing Liu,
Qi Zhang,
Jiyu Wang
et al.

Abstract: Increased stemness is causally linked to the development of chemoresistance in cancers. B-cell receptor-associated protein 31 (BAP31) has been identified to play an oncogenic role in many types of cancer. However, the role of BAP31 in 5-fluorouracil (5-FU) chemosensitivity and stemness of colorectal cancer (CRC) is still unknown. The aim of this study was to investigate the biological function and molecular mechanism of BAP31 in regulating 5-FU chemosensitivity and stemness. The correlation between BAP31 expre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 65 publications
0
4
0
Order By: Relevance
“…Moreover, antibodies that clearly work in advanced colon cancer through a signaling blockade during angiogenesis did not show relevant benefits in patients with pancreatic cancer. To overcome the limitation of desirable intracellular signaling blockades in tumor cells, intrabodies have been designed that are capable of targeting intracellular tumor-associated antigens and neoantigens in cells and xenograft mouse models [27,29,[51][52][53][54][55][56][57][58][59][60]. This strongly supports the further development of relevant intrabodies, with the goal of setting up clinical trials.…”
Section: Discussionmentioning
confidence: 89%
“…Moreover, antibodies that clearly work in advanced colon cancer through a signaling blockade during angiogenesis did not show relevant benefits in patients with pancreatic cancer. To overcome the limitation of desirable intracellular signaling blockades in tumor cells, intrabodies have been designed that are capable of targeting intracellular tumor-associated antigens and neoantigens in cells and xenograft mouse models [27,29,[51][52][53][54][55][56][57][58][59][60]. This strongly supports the further development of relevant intrabodies, with the goal of setting up clinical trials.…”
Section: Discussionmentioning
confidence: 89%
“…HIF-1α positively correlated with BAP31 overexpression, and the knockdown of BAP31 reduced the expression of HIF-1α despite protein stabilization with MG132 ( Figure 3 ). In a recent study, BAP31 knockdown positively correlated with GAL-3 in colorectal cancer and affected cancer cell stemness [ 22 ]. These findings underscore the role of BAP31 in mediating the expression of GAL-3 and VEGFA in neuroblastoma.…”
Section: Discussionmentioning
confidence: 99%
“…BAP31 is linked to cancer cell proliferation, metastasis, and shortened survival [ 19 , 20 , 21 ]. Recently, BAP31 was reported to promote angiogenesis in colorectal cancer [ 22 ]. Due to its widespread expression, BAP31 has emerged as a promising candidate for potential cancer therapy strategies aimed at inducing apoptosis and advancing vaccine development.…”
Section: Introductionmentioning
confidence: 99%
“…This kind of bidirectional relationship often implies a feedback loop, where the activation of one component influences the activity of the other, creating a dynamic regulatory network. The identification of Gal-3 as a novel binding partner of β-catenin adds another layer to the complexity of the interactions between Gal-3 and signaling pathways related to cell proliferation and survival [42]. The involvement of Gal-3 in various cellular processes, including its associations with NF-κB and β-catenin, suggests a multifaceted role for Gal-3 in modulating cell functions and responses to stress or inflammation.…”
Section: Discussionmentioning
confidence: 99%